NAMS Menopause Certification Exam Questions and Answers
GUARANTEED PASS!!
Median age of natural menopause - (ANSWER)51 years
Characteristic hormonal change in menopause transition - (ANSWER)Declining estrogen
Reproductive stage of a 49-year-old with irregular periods and vasomotor symptoms -
(ANSWER)Perimenopause
Definition of postmenopause - (ANSWER)12 consecutive months without menstruation
Laboratory finding supporting menopause diagnosis in a 52-year-old woman - (ANSWER)Elevated FSH
(>25 IU/L)
Most effective treatment for moderate-to-severe hot flashes - (ANSWER)Hormone therapy
Hormone therapy regimen for postmenopausal woman with intact uterus - (ANSWER)Estrogen plus
progestogen
Recommended treatment for hot flashes in breast cancer survivor - (ANSWER)Paroxetine
Contraindication for systemic hormone therapy - (ANSWER)Unexplained vaginal bleeding
Non-hormonal medication effective for menopausal sleep disturbances - (ANSWER)Gabapentin
Primary risk factor for osteoporosis in postmenopausal women - (ANSWER)Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan - (ANSWER)Osteoporosis
Page 1 of 10
, Gabapentin - (ANSWER)Improves sleep and reduces hot flashes in menopausal women.
T-score of -2.8 on DEXA scan - (ANSWER)Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment - (ANSWER)Bisphosphonates.
Recommended daily calcium intake for women aged 51-70 years - (ANSWER)1200 mg.
Medication that reduces fracture risk and breast cancer risk - (ANSWER)Raloxifene.
Cardiovascular risk factor that increases significantly after menopause - (ANSWER)Coronary artery
disease.
Contributing factor to elevated LDL cholesterol post-menopause - (ANSWER)Estrogen decline.
Common metabolic change in postmenopausal women - (ANSWER)Increased visceral fat.
Most effective intervention to reduce cardiovascular risk in postmenopausal women -
(ANSWER)Lifestyle modification.
Best approach for a woman on HT asking about cardiovascular safety - (ANSWER)Use lowest effective
dose.
Most common symptom of genitourinary syndrome of menopause (GSM) - (ANSWER)Vaginal dryness.
First-line treatment for vaginal atrophy in postmenopausal women - (ANSWER)Vaginal estrogen.
Likely cause of dyspareunia in a 57-year-old woman - (ANSWER)Vaginal atrophy.
Intervention that improves sexual function in postmenopausal women - (ANSWER)Vaginal moisturizers.
Page 2 of 10
GUARANTEED PASS!!
Median age of natural menopause - (ANSWER)51 years
Characteristic hormonal change in menopause transition - (ANSWER)Declining estrogen
Reproductive stage of a 49-year-old with irregular periods and vasomotor symptoms -
(ANSWER)Perimenopause
Definition of postmenopause - (ANSWER)12 consecutive months without menstruation
Laboratory finding supporting menopause diagnosis in a 52-year-old woman - (ANSWER)Elevated FSH
(>25 IU/L)
Most effective treatment for moderate-to-severe hot flashes - (ANSWER)Hormone therapy
Hormone therapy regimen for postmenopausal woman with intact uterus - (ANSWER)Estrogen plus
progestogen
Recommended treatment for hot flashes in breast cancer survivor - (ANSWER)Paroxetine
Contraindication for systemic hormone therapy - (ANSWER)Unexplained vaginal bleeding
Non-hormonal medication effective for menopausal sleep disturbances - (ANSWER)Gabapentin
Primary risk factor for osteoporosis in postmenopausal women - (ANSWER)Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan - (ANSWER)Osteoporosis
Page 1 of 10
, Gabapentin - (ANSWER)Improves sleep and reduces hot flashes in menopausal women.
T-score of -2.8 on DEXA scan - (ANSWER)Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment - (ANSWER)Bisphosphonates.
Recommended daily calcium intake for women aged 51-70 years - (ANSWER)1200 mg.
Medication that reduces fracture risk and breast cancer risk - (ANSWER)Raloxifene.
Cardiovascular risk factor that increases significantly after menopause - (ANSWER)Coronary artery
disease.
Contributing factor to elevated LDL cholesterol post-menopause - (ANSWER)Estrogen decline.
Common metabolic change in postmenopausal women - (ANSWER)Increased visceral fat.
Most effective intervention to reduce cardiovascular risk in postmenopausal women -
(ANSWER)Lifestyle modification.
Best approach for a woman on HT asking about cardiovascular safety - (ANSWER)Use lowest effective
dose.
Most common symptom of genitourinary syndrome of menopause (GSM) - (ANSWER)Vaginal dryness.
First-line treatment for vaginal atrophy in postmenopausal women - (ANSWER)Vaginal estrogen.
Likely cause of dyspareunia in a 57-year-old woman - (ANSWER)Vaginal atrophy.
Intervention that improves sexual function in postmenopausal women - (ANSWER)Vaginal moisturizers.
Page 2 of 10
